newsfilter
← Latest News
PR Newswire·

Viking Therapeutics to Report Financial Results for Third Quarter 2026 on October 28, 2026

Conference Call Scheduled for Wednesday, October 28, at 4:30 p.m. Eastern Time SAN DIEGO, Oct. 21, 2026 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ:VKTX), a clinical-stage biopharmaceutical